Pangaea Data appoints new CFO and three pharmaceutical experts as advisors Pangaea Data appoints new CFO and three pharmaceutical experts as advisors New hires will help drive commercial growth and expansion into the US
London, 29 March: Pangaea Data, the UK company that provides a novel AI based software product to its customers from the biopharmaceutical and healthcare industry, has appointed Mr Simon Coulthard as the new CFO, Professor Mark Musen, Dr. Rick Sax and Mr Ozgur Tuncer to its Scientific Advisory Board (SAB).
Mr Simon Coulthard is a Fellow of the Chartered Institute of Management Accountants with thirty years of accounting and financial leadership experience. He joins Pangaea from Congenica, a cutting-edge digital health company spun out of the Wellcome Sanger Institute, where he was instrumental in their recent $50m Series C funding round. Simon has grown companies from early stage to market leaders, has experienced private equity backed buy-outs and has exited companies through secondary sales, doubling the enterprise value to £55m in 18 months. He will leverage a decade of international experience in software development and the recent global growth in Congenica's digital health platform to accelerate expansion into Pangaea's key strategic markets within the US healthcare and pharmaceutical industry. Simon will be in charge of the financial reporting, planning and analysis, accounting, business intelligence, and controls to ensure that governance and other financial foundations are in place to support the rapid expansion of commercial operations, on a global scale.